Drug intelligence / Profile preview

choline alfoscerate

Development stage
Phase 4
Lead developer
Italfarmaco
Modality
Small Molecules
Administration
Oral
01

Overview

Choline alfoscerate (alpha-glycerylphosphorylcholine) is a parasympathomimetic acetylcholine precursor used primarily for cognitive enhancement in dementia and Alzheimer's disease. It works by increasing the synthesis and release of acetylcholine in the brain and providing glycerophosphate for neuronal membrane repair. Clinically, it is approved in several countries, including South Korea and Italy, for Alzheimer's disease, vascular dementia, and cognitive impairment following stroke. Recent research has expanded its potential applications to include the treatment of dry eye disease (keratoconjunctivitis sicca), where it may act as a surfactant and anti-inflammatory agent, and the management of depressive symptoms and insulin resistance in elderly diabetic patients. It is also being investigated for its neuroprotective effects in glioblastoma and ischemic stroke recovery.

Brand names
GliatilinGliatamin
Other names
alpha-GPCL-alpha-glycerylphosphorylcholineGPCcholine alphosceratealpha glycerylphosphorylcholine
02

Targets

Nicotinic Acetylcholine ReceptormAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on choline alfoscerate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on choline alfoscerate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call